Nuvation Bio Inc. (NUVB) Tops Q3 EPS by 2c

Nuvation Bio Inc. (NYSE: NUVB) reported Q3 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c